With solid financials and subscriber gains that beat expectations, Rogers Communications’ (TSX:RCI.B) newly released first quarter results are a cause for a revised forecast but not enough to move the target price, says analyst Rob Goff of Echelon Wealth Partners, who on Thursday maintained his “Buy” recommendation and $72.00 target. Yesterday, Rogers released its Q1/18 […]
Canopy Growth Corp. and other Canadian pot stocks are still cheap, this U.S. investor says
It’s 4/20 Day around the world, and in Canada that means both cannabis stocks and the impending rec legalization are on everyone’s mind. But with nine US states plus the District of Columbia having now legalized rec cannabis, Americans are wondering if the Canuck pot stocks are a good investment. Definitely, says Tim Seymour, “Fast […]
Imaflex has a 122 per cent upside, Beacon Securities says
Beacon Securities analyst Ahmad Shaath is bullish on packaging and agricultural film company Imaflex Inc. (TSXV:IFX), saying that its just-released Q4 and year ended 2017 financials show promising improvement in the company’s core business. In a client update on Friday, the analyst reiterated his “Buy” rating with a lowered target price of $2.00, representing a […]
Antibe Therapeutics has a 192 per cent upside, Echelon Wealth says
In a coverage launch on Thursday, Echelon Wealth Partners analyst Douglas Loe says clinical stage drug developer Antibe Therapeutics (TSXV:ATE) has positive Phase II data on a drug that could benefit patients with chronic pain who take non-steroid anti-inflammatory drugs (NSAIDs). Loe rates Antibe a “Speculative Buy” with a one-year target price of $1.40, implying […]
BCE stock is becoming downright cheap, this investor says
Shares of telecom giant BCE Inc. (TSX:BCE, NYSE:BCE) has been heading south for a good four months now. Is there sign of a turnaround? Probably not in the near term, says Ross Healy of Strategic Analysis Corp., who nevertheless believes there’s a buying opportunity coming up. BCE’s slide has taken it from a high of […]
The medical marijuana industry is about to get much bigger, CannTrust CEO says
While all eyes are on the launch date for recreational cannabis in Canada —said to come in either late summer or early fall— the medical side of the equation should be getting the attention, as well, because it’s about to get much bigger, says Eric Paul, CEO of licensed producer CannTrust Holdings (TSX:TRST). The ramp […]
Oncolytics Biotech’s latest results are promising, Paradigm Capital says
New research results from clinical-stage oncology company Oncolytics Biotech (TSX:ONC) show potential in the lucrative sector of immuno oncology (I/O), says Rahul Sarugaser, analyst with Paradigm Capital, who on Thursday reiterated his “Speculative Buy” recommendation and 12-month target price of $3.25. This week, Oncolytics Biotech presented preclinical data on its lead drug candidate REOLYSIN (REO) […]
Kinaxis is fully valued, Industrial Alliance Securities says
Ahead of Q1 financial results from Kinaxis Inc. (TSX:KXS), Blair Abernethy of Industrial Alliance Securities said on Wednesday that although the software company is still in the early stages of a potentially long-term growth opportunity in the supply chain management sector, he would like to see a more robust revenue growth rate before moving from […]
We sold Berkshire Hathaway because buy and hold forever is dead, this investor says
With both chief executive Warren Buffett and vice chairman Charlie Munger now well past traditional retirement age —and with Buffett yet to name his successor— should investors be wary of Berkshire Hathaway? Not really, says Contra the Heard’s Benj Gallander, who at the same time expects a selloff when Buffett passes away. The Oracle of […]
Square Inc. has lots of growth left, this fund manager says
If you think the share price for mobile payment company Square, Inc. (NYSE:SQ) has gotten too rich, think again — there’s still lots of upside, says David Burrows of Barometer Capital, who argues that growth in the digital payment sector is far from over. So far, Square’s 2018 has been eventful, to say the least. […]
- 1
- 2
- 3
- …
- 255
- Next Page »